期刊文献+

大鼠品系及药物剂量对糖尿病大鼠模型的影响 被引量:15

EFFECTS OF STREPTOZOCIN DOSAGE AND THE STRAINS OF RATS ON ESTABLISHING DIABETES MELLITUS ANIMAL MODEL
下载PDF
导出
摘要 目的:通过一次性注射链脲佐菌素(STZ)制作大鼠糖尿病模型,观察大鼠品系、给药剂量对大鼠成模率、死亡率的影响。方法:Wistar、SD大鼠雄性各50只,随机分组为正常对照和剂量组(STZ1组:55mg/kg,2组:45 mg/kg,3组:35 mg/kg,4组:25 mg/kg),腹腔注射STZ,48小时后观察血糖,8周后计算死亡率,病理切片观察胰岛细胞。结果:Wistar、SD大鼠55mg/kg组全部成模,死亡率分别是100%、90%;45 mg/kg组全部成模,死亡率40%、28%;35 mg/kg组成模率为100%、30%,零死亡;25 mg/kg组成模率为70%、0%,零死亡。结论:35mg/kg剂量Wistar大鼠,成模率高,死亡率低,且结果优于SD大鼠。 Objective:To investigate the effects of streptozocin(STZ) dosage and the strains of rats on the incidence and mortality of diabetes mellitus animal model.Methods:50 Wistar male rats and 50 SD male rats were randomly divided into normal control group and dose group;dose group were injected intraperitoneally with different dose of STZ(group 1,STZ 55mg/kg,group 2,STZ 45 mg/kg,group 3,STZ 35 mg/kg,group 4,STZ 25 mg/kg).Then,the blood glucose was measured after 48 hours,calculating mortality and to observe pathological change of islet cells after 8 weeks.Results:1 The incidence of diabetes mellitus:was 100% in both group 1 and group 2,of both Wistar rats and SD rats.But in group 3,it was 100% in Wistar rats,but only 30% in SD rats;in group 4,it was 70% in Wistar rats,0% in SD rats.2.The mortality rate:in group 1 was 100% in wistar rats,90% in SD rats;in group 2,it was 40% in wistar rats,28% in SD rats,and it was 0% in either wistar rats or SD rats in both group 3 and group 4.Conclusion:The incidence is higher and the mortality rate is lower for wistar rats with moderate dose of STZ(35mg/kg).
出处 《泸州医学院学报》 2011年第2期156-158,共3页 Journal of Luzhou Medical College
关键词 链脲佐菌素 糖尿病 成模 大鼠 Streptozotocin Diabetes mellitus DM model establishment Rat
  • 相关文献

参考文献5

  • 1张新兰,张兰.体重因素对链脲佐菌素所致糖尿病大鼠模型的影响[J].辽宁中医药大学学报,2008,10(5):179-179. 被引量:7
  • 2李聪然,游雪甫,蒋建东.糖尿病动物模型及研究进展[J].中国比较医学杂志,2005,15(1):59-63. 被引量:93
  • 3R.ackietan N,Rackietan M L,Nadkami M R..Studies on diabe togenic action of streptozotocin (NSC-367917)[J]. Cancer Chemother Rep, 1963 ; 29 : 91.
  • 4Marcelo A.Nobrega,Stewart Fleming,RichardJ.R.oman, etal.lnitial Characteriz -ation of a Rat Model of Diabetic Nephropathy[J] .DIABETES,2004 ; 53:735.
  • 5Zhonghua Qi,Hiroki FujitaJingping Jin,et al. Characte- rization of Susceptibility of Inbred Mouse Strains to Diabetic Nephrpathy[J].DIABETES,2005; 54:2628.

二级参考文献35

  • 1蒋虹,王艳蓉,张永蓉,汪歌.NOD小鼠糖尿病病症的初步观察[J].中国实验动物学杂志,1998,8(3):157-159. 被引量:3
  • 2毛向群,朱丽萍.2型糖尿病防制进展[J].江西医药,2005,40(2):107-109. 被引量:5
  • 3付晓,李敬林,卞镝,董天宝.糖克煎剂对糖尿病大鼠肾脏病理组织结构的影响[J].中医药学刊,2006,24(4):657-658. 被引量:7
  • 4[4]Lynch JJ,Jarvis MF,Kowaluk EA.An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain[J].Eur J Pharmacol,1999,364 (2/3):141-146.
  • 5杜冠华 李学军 张永祥 等译.药理学实验指南-新药发现和药理学评价[T].北京:科学出版社,2001.698-712.
  • 6Rossini AA, Williams RM, Appel MC, et al. Sex difference in the multiple-dose streptozotocin model of diabetes [J]. Endocrinology,1978,103: 1518 - 1520.
  • 7Anastasi E, Dotta F, Tiberti C, et al. Insulin prophylaxis down-regulates islet antigen expression and islet autoimmunity in the low-dose Stz mouse model of diabetes [ J ]. Autoimmunity, 1999, 29:249 -256.
  • 8Bach JF. Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases[ J]. Arthritis Res, 2002, Suppl 3: S1 - S15.
  • 9Shimada A, Charlton B, Taylor-Edwards C, et al. Beta-cell destruction may be a late consequence of the autoimmune process in nonobese diabetes mice[J]. Diabetes, 1996, 45(8): 1063 - 1067.
  • 10Baeder WL, Sredy J, Sehgal SN, et al. Rapamycin prevents the onset of insulin dependent diabetes mellitus (IDDM) in NOD mice[J].Clin Exp Immunol, 1992,89:174 - 178.

共引文献97

同被引文献209

引证文献15

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部